Late-stage functionalization is an attractive strategy that allows chemists to bypass lengthy synthetic processes,facilitating the rapid generation of drug analogs with potentially enhanced pharmacokinetic and pharmac...Late-stage functionalization is an attractive strategy that allows chemists to bypass lengthy synthetic processes,facilitating the rapid generation of drug analogs with potentially enhanced pharmacokinetic and pharmacological properties.This study describes a novel approach for cross-dehydrogenative oxyalkylation,leveraging a unique g-ray-enabled photoredox process to generate oxyalkyl radicals,followed by a Minisci-type addition in an aqueous solution.The metal-and oxidant-free aqueous conditions,coupled with excellent functional group compatibility,establish this method as a versatile protocol for the late-stage oxyalkylation of unprotected,structurally complex drug molecules.Notably,this method demonstrated improved pharmacokinetics in hydroxymethylated fibroblast activation protein inhibitor(FAPI)molecules,highlighting its potential to accelerate drug discovery efforts.展开更多
基金funded by the Ministry of Science and Technology of the People’s Republic of China(2021YFA1601400)the National Natural Science Foundation of China(22225603 and 22441051)the New Cornerstone Science Foundation(The XPLORER PRIZE)and Changping Laboratory to Z.L.,and the National Nature Science Foundation of China(22306005)to B.-S.M.
文摘Late-stage functionalization is an attractive strategy that allows chemists to bypass lengthy synthetic processes,facilitating the rapid generation of drug analogs with potentially enhanced pharmacokinetic and pharmacological properties.This study describes a novel approach for cross-dehydrogenative oxyalkylation,leveraging a unique g-ray-enabled photoredox process to generate oxyalkyl radicals,followed by a Minisci-type addition in an aqueous solution.The metal-and oxidant-free aqueous conditions,coupled with excellent functional group compatibility,establish this method as a versatile protocol for the late-stage oxyalkylation of unprotected,structurally complex drug molecules.Notably,this method demonstrated improved pharmacokinetics in hydroxymethylated fibroblast activation protein inhibitor(FAPI)molecules,highlighting its potential to accelerate drug discovery efforts.
